Problemas bioéticos na prática interequipes em uma unidade de Atenção Primária à Saúde no Brasil

The objective of this work is to analyze the origin and the bioethical problems arising in the work process amongst teams in a Primary Health Care unit in Brazil. This qualitative research has three stages of operationalization: ethnography, interview, and focus group. The main bioethical problem found, which compromises the production of care at this level, is the lack of solidarity amongst the professionals in the teams and with the patients who do not belong to the sector of the territory under their responsibility. The reasons for this bioethical problem are associated with municipal management collection to increase production and the achievement of goals, the little appreciation for the team workers and their efforts at the job from the management and an asymmetric esteem. In this sense, bioethics in the context of public health becomes understanding and discussing the problems experienced to establish a framework of moral conscience and ethical action. At certain moments, a solidarity contribution from others, materialized in the recognition of being part of that production, is necessary for the effectiveness of a team.El objetivo de este trabajo es analizar el origen y los problemas bioéticos que emergen en el proceso de trabajo entre equipos en una unidad de Atención Primaria a la Salud en Brasil. Esta investigación cualitativa cuenta con tres etapas de operacionalización: etnografía, entrevista y grupo focal. El principal problema bioético encontrado, que compromete la producción del cuidado en ese nivel de atención, es la falta de solidaridad entre los profesionales de los equipos y de esos hacia lospacientes que no pertenecen al sector del territorio bajo su responsabilidad. Las razones de este problema bioético están asociadas al cobro de la gestión municipal para el incremento de la producción y el alcance de metas, a la falta de valoración de los trabajadores de los equipos y de los esfuerzos emprendidos por ellos en el trabajo por parte de la gestión y la estima asimétrica. En este sentido, la bioética en el contexto de la salud pública se convierte en comprender y discutir los problemas experimentados para establecer un marco de conciencia moral y acción ética. En determinados momentos, para la efectividad de un equipo es necesario el aporte solidario de los otros, concretado por el reconocimiento de pertenencia a esa producción.O objetivo deste trabalho é analisar a origem e os problemas bioéticos que emergem no processo de trabalho entre equipes em uma unidade de Atenção Primária à Saúde no Brasil. Esta investigação qualitativa conta com três etapas de operacionalização: etnografia, entrevista e grupo focal. O principal problema bioético encontrado, que compromete a produção do cuidado nesse nível de atenção, é a falta de solidariedade entre os profissionais das equipes e destes com os pacientes que não pertencem ao setor do território sob a sua responsabilidade. As razões desse problema bioético estão associadas à cobrança da gestão municipal para o incremento da produção e o alcance de metas, à falta de valorização dos trabalhadores das equipes e dos esforços empreendidos por eles no trabalho por parte da gestão e à estima assimétrica. Nesse sentido, a Bioética, no contexto da saúde pública, volta-se para a compreensão e discussão dos problemas vivenciados a fim de estabelecer um quadro de consciência moral e agir ético. Em determinados momentos, para a efetividade de uma equipe, é necessário o aporte solidário das outras, concretizado pelo reconhecimento de pertença a essa produção

Equidade no acesso ao transplante de rim com doador falecido no estado do Rio de Janeiro

No Brasil, o transplante é um direito da sociedade; entretanto, a escassez de órgãos de doadores falecidos tem refletido no aumento da demanda por transplante. Nesse contexto, o presente trabalho tem como objetivo analisar o acesso ao transplante de rim no Estado do Rio de Janeiro sob a ótica da equidade. Buscou-se pelos prontuários identificar e analisar dentre os não transplantados classificados para transplante de rim no ano de 2008 os fatores que dificultam o acesso, a partir das etapas necessárias para que o potencial receptor se submeta ao transplante. Baseou-se no consenso de que a Equidade é um princípio constitucional e do Sistema Único de Saúde e que as opções conceituais influenciam na escolha de critérios distributivos, nos indicadores utilizados para avaliar o grau de equidade e na interpretação dos resultados para efetividade das intervenções. Entre os resultados, destaca-se o "soro vencido" como principal obstáculo de não transplante dentre os classificados, seguidos de "Não informado", "Contato telefônico"; "Sem condições clínicas"; "Contraindicação pela equipe transplantadora"; "Sem exame" e "Outros". Contatou-se que o atual critério de seleção para transplante de rim apresenta inúmeros limites à implementação de forma equitativa, principalmente no que tange à organização da rede e no consumo de serviços de saúde. A política nacional de transplante apresenta ainda uma rede desarticulada que não é capaz de garantir o acesso às ações e serviços de saúde, não contemplando assim todas as necessidades de saúde da população usuária dos serviços de transplante no Estado do Rio de Janeiro

Equidade no acesso ao transplante de rim com doador falecido no estado do Rio de Janeiro

In Brazil, the transplant is a right of society, however the shortage of organs from deceased donors has been reflected in increased demand for transplantation. In this context, this paper aims to analyze access to kidney transplantation in the State of Rio de Janeiro from the perspective of fairness. We sought to identify through the charts and analysis from the non-transplanted qualified for kidney transplantation in 2008 the factors that hinder access, from the steps required for the potential recipient to undergo transplantation. Based on the consensus that equity is a constitutional principle and the Health System and the conceptual options influence the choice of distributive criteria, the indicators used to assess the degree of equity and interpretation of results for the effectiveness of interventions. Among the results, we highlight the "serum loser" as the main obstacle is not classified among the transplant, followed by "not informed", "Contact Phone", "Without clinical conditions"; "Contra-indication for transplantation teams"; "without examination" and "Other". It was noted that the current selection criteria for kidney transplantation has many limits to implement fairly, especially concerning the organization of the network and consumption of health services. The national policy on transplantation still presents a disjointed network that is unable to ensure access to the actions and health services, thus not allowing all health needs of the user population of transplant services in the State of Rio de Janeiro.No Brasil, o transplante é um direito da sociedade; entretanto, a escassez de órgãos de doadores falecidos tem refletido no aumento da demanda por transplante. Nesse contexto, o presente trabalho tem como objetivo analisar o acesso ao transplante de rim no Estado do Rio de Janeiro sob a ótica da equidade. Buscou-se pelos prontuários identificar e analisar dentre os não transplantados classificados para transplante de rim no ano de 2008 os fatores que dificultam o acesso, a partir das etapas necessárias para que o potencial receptor se submeta ao transplante. Baseou-se no consenso de que a Equidade é um princípio constitucional e do Sistema Único de Saúde e que as opções conceituais influenciam na escolha de critérios distributivos, nos indicadores utilizados para avaliar o grau de equidade e na interpretação dos resultados para efetividade das intervenções. Entre os resultados, destaca-se o "soro vencido" como principal obstáculo de não transplante dentre os classificados, seguidos de "Não informado", "Contato telefônico"; "Sem condições clínicas"; "Contra-indicação pela equipe transplantadora"; "Sem exame" e "Outros". Contatou-se que o atual critério de seleção para transplante de rim apresenta inúmeros limites à implementação de forma equitativa, principalmente no que tange à organização da rede e no consumo de serviços de saúde. A política nacional de transplante apresenta ainda uma rede desarticulada que não é capaz de garantir o acesso às ações e serviços de saúde, não contemplando assim todas as necessidades de saúde da população usuária dos serviços de transplante no Estado do Rio de Janeiro

Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019 : A systematic analysis for the Global Burden of Disease Study 2019

Background Achieving universal health coverage (UHC) involves all people receiving the health services they need, of high quality, without experiencing financial hardship. Making progress towards UHC is a policy priority for both countries and global institutions, as highlighted by the agenda of the UN Sustainable Development Goals (SDGs) and WHO's Thirteenth General Programme of Work (GPW13). Measuring effective coverage at the health-system level is important for understanding whether health services are aligned with countries' health profiles and are of sufficient quality to produce health gains for populations of all ages. Methods Based on the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, we assessed UHC effective coverage for 204 countries and territories from 1990 to 2019. Drawing from a measurement framework developed through WHO's GPW13 consultation, we mapped 23 effective coverage indicators to a matrix representing health service types (eg, promotion, prevention, and treatment) and five population-age groups spanning from reproductive and newborn to older adults (≥65 years). Effective coverage indicators were based on intervention coverage or outcome-based measures such as mortality-to-incidence ratios to approximate access to quality care; outcome-based measures were transformed to values on a scale of 0–100 based on the 2·5th and 97·5th percentile of location-year values. We constructed the UHC effective coverage index by weighting each effective coverage indicator relative to its associated potential health gains, as measured by disability-adjusted life-years for each location-year and population-age group. For three tests of validity (content, known-groups, and convergent), UHC effective coverage index performance was generally better than that of other UHC service coverage indices from WHO (ie, the current metric for SDG indicator 3.8.1 on UHC service coverage), the World Bank, and GBD 2017. We quantified frontiers of UHC effective coverage performance on the basis of pooled health spending per capita, representing UHC effective coverage index levels achieved in 2019 relative to country-level government health spending, prepaid private expenditures, and development assistance for health. To assess current trajectories towards the GPW13 UHC billion target—1 billion more people benefiting from UHC by 2023—we estimated additional population equivalents with UHC effective coverage from 2018 to 2023. Findings Globally, performance on the UHC effective coverage index improved from 45·8 (95% uncertainty interval 44·2–47·5) in 1990 to 60·3 (58·7–61·9) in 2019, yet country-level UHC effective coverage in 2019 still spanned from 95 or higher in Japan and Iceland to lower than 25 in Somalia and the Central African Republic. Since 2010, sub-Saharan Africa showed accelerated gains on the UHC effective coverage index (at an average increase of 2·6% [1·9–3·3] per year up to 2019); by contrast, most other GBD super-regions had slowed rates of progress in 2010–2019 relative to 1990–2010. Many countries showed lagging performance on effective coverage indicators for non-communicable diseases relative to those for communicable diseases and maternal and child health, despite non-communicable diseases accounting for a greater proportion of potential health gains in 2019, suggesting that many health systems are not keeping pace with the rising non-communicable disease burden and associated population health needs. In 2019, the UHC effective coverage index was associated with pooled health spending per capita (r=0·79), although countries across the development spectrum had much lower UHC effective coverage than is potentially achievable relative to their health spending. Under maximum efficiency of translating health spending into UHC effective coverage performance, countries would need to reach $1398 pooled health spending per capita (US$ adjusted for purchasing power parity) in order to achieve 80 on the UHC effective coverage index. From 2018 to 2023, an estimated 388·9 million (358·6–421·3) more population equivalents would have UHC effective coverage, falling well short of the GPW13 target of 1 billion more people benefiting from UHC during this time. Current projections point to an estimated 3·1 billion (3·0–3·2) population equivalents still lacking UHC effective coverage in 2023, with nearly a third (968·1 million [903·5–1040·3]) residing in south Asia. Interpretation The present study demonstrates the utility of measuring effective coverage and its role in supporting improved health outcomes for all people—the ultimate goal of UHC and its achievement. Global ambitions to accelerate progress on UHC service coverage are increasingly unlikely unless concerted action on non-communicable diseases occurs and countries can better translate health spending into improved performance. Focusing on effective coverage and accounting for the world's evolving health needs lays the groundwork for better understanding how close—or how far—all populations are in benefiting from UHC

Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017

A double burden of malnutrition occurs when individuals, household members or communities experience both undernutrition and overweight. Here, we show geospatial estimates of overweight and wasting prevalence among children under 5 years of age in 105 low- and middle-income countries (LMICs) from 2000 to 2017 and aggregate these to policy-relevant administrative units. Wasting decreased overall across LMICs between 2000 and 2017, from 8.4% (62.3 (55.1–70.8) million) to 6.4% (58.3 (47.6–70.7) million), but is predicted to remain above the World Health Organization’s Global Nutrition Target of <5% in over half of LMICs by 2025. Prevalence of overweight increased from 5.2% (30 (22.8–38.5) million) in 2000 to 6.0% (55.5 (44.8–67.9) million) children aged under 5 years in 2017. Areas most affected by double burden of malnutrition were located in Indonesia, Thailand, southeastern China, Botswana, Cameroon and central Nigeria. Our estimates provide a new perspective to researchers, policy makers and public health agencies in their efforts to address this global childhood syndemic

Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

Background: In an era of shifting global agendas and expanded emphasis on non-communicable diseases and injuries along with communicable diseases, sound evidence on trends by cause at the national level is essential. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides a systematic scientific assessment of published, publicly available, and contributed data on incidence, prevalence, and mortality for a mutually exclusive and collectively exhaustive list of diseases and injuries. Methods: GBD estimates incidence, prevalence, mortality, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) due to 369 diseases and injuries, for two sexes, and for 204 countries and territories. Input data were extracted from censuses, household surveys, civil registration and vital statistics, disease registries, health service use, air pollution monitors, satellite imaging, disease notifications, and other sources. Cause-specific death rates and cause fractions were calculated using the Cause of Death Ensemble model and spatiotemporal Gaussian process regression. Cause-specific deaths were adjusted to match the total all-cause deaths calculated as part of the GBD population, fertility, and mortality estimates. Deaths were multiplied by standard life expectancy at each age to calculate YLLs. A Bayesian meta-regression modelling tool, DisMod-MR 2.1, was used to ensure consistency between incidence, prevalence, remission, excess mortality, and cause-specific mortality for most causes. Prevalence estimates were multiplied by disability weights for mutually exclusive sequelae of diseases and injuries to calculate YLDs. We considered results in the context of the Socio-demographic Index (SDI), a composite indicator of income per capita, years of schooling, and fertility rate in females younger than 25 years. Uncertainty intervals (UIs) were generated for every metric using the 25th and 975th ordered 1000 draw values of the posterior distribution. Findings: Global health has steadily improved over the past 30 years as measured by age-standardised DALY rates. After taking into account population growth and ageing, the absolute number of DALYs has remained stable. Since 2010, the pace of decline in global age-standardised DALY rates has accelerated in age groups younger than 50 years compared with the 1990–2010 time period, with the greatest annualised rate of decline occurring in the 0–9-year age group. Six infectious diseases were among the top ten causes of DALYs in children younger than 10 years in 2019: lower respiratory infections (ranked second), diarrhoeal diseases (third), malaria (fifth), meningitis (sixth), whooping cough (ninth), and sexually transmitted infections (which, in this age group, is fully accounted for by congenital syphilis; ranked tenth). In adolescents aged 10–24 years, three injury causes were among the top causes of DALYs: road injuries (ranked first), self-harm (third), and interpersonal violence (fifth). Five of the causes that were in the top ten for ages 10–24 years were also in the top ten in the 25–49-year age group: road injuries (ranked first), HIV/AIDS (second), low back pain (fourth), headache disorders (fifth), and depressive disorders (sixth). In 2019, ischaemic heart disease and stroke were the top-ranked causes of DALYs in both the 50–74-year and 75-years-and-older age groups. Since 1990, there has been a marked shift towards a greater proportion of burden due to YLDs from non-communicable diseases and injuries. In 2019, there were 11 countries where non-communicable disease and injury YLDs constituted more than half of all disease burden. Decreases in age-standardised DALY rates have accelerated over the past decade in countries at the lower end of the SDI range, while improvements have started to stagnate or even reverse in countries with higher SDI. Interpretation: As disability becomes an increasingly large component of disease burden and a larger component of health expenditure, greater research and developm nt investment is needed to identify new, more effective intervention strategies. With a rapidly ageing global population, the demands on health services to deal with disabling outcomes, which increase with age, will require policy makers to anticipate these changes. The mix of universal and more geographically specific influences on health reinforces the need for regular reporting on population health in detail and by underlying cause to help decision makers to identify success stories of disease control to emulate, as well as opportunities to improve. Funding: Bill & Melinda Gates Foundation. © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 licens